SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023776
Filing Date
2017-11-14
Accepted
2017-11-14 16:17:24
Documents
47
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20170930.htm 10-Q 1582090
2 EX-10.4 life-ex104_391.htm EX-10.4 107707
3 EX-10.5 life-ex105_390.htm EX-10.5 111366
4 EX-31.1 life-ex311_28.htm EX-31.1 9619
5 EX-31.2 life-ex312_27.htm EX-31.2 9137
6 EX-32.1 life-ex321_25.htm EX-32.1 5510
7 EX-32.2 life-ex322_26.htm EX-32.2 5521
  Complete submission text file 0001564590-17-023776.txt   5689818

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT life-20170930.xml EX-101.INS 1247371
9 XBRL TAXONOMY EXTENSION SCHEMA life-20170930.xsd EX-101.SCH 35648
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20170930_cal.xml EX-101.CAL 34678
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20170930_def.xml EX-101.DEF 143218
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20170930_lab.xml EX-101.LAB 300199
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20170930_pre.xml EX-101.PRE 225520
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 171201761
SIC: 2836 Biological Products, (No Diagnostic Substances)